Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

The nociceptin receptor inhibits axonal regeneration and recovery from spinal cord injury.

Sekine Y, Siegel CS, Sekine-Konno T, Cafferty WBJ, Strittmatter SM.

Sci Signal. 2018 Apr 3;11(524). pii: eaao4180. doi: 10.1126/scisignal.aao4180.

2.

Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer's disease mouse model.

Nygaard HB, Kaufman AC, Sekine-Konno T, Huh LL, Going H, Feldman SJ, Kostylev MA, Strittmatter SM.

Alzheimers Res Ther. 2015 May 5;7(1):25. doi: 10.1186/s13195-015-0110-9. eCollection 2015.

3.

A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease.

Nygaard HB, Wagner AF, Bowen GS, Good SP, MacAvoy MG, Strittmatter KA, Kaufman AC, Rosenberg BJ, Sekine-Konno T, Varma P, Chen K, Koleske AJ, Reiman EM, Strittmatter SM, van Dyck CH.

Alzheimers Res Ther. 2015 Apr 14;7(1):35. doi: 10.1186/s13195-015-0119-0. eCollection 2015.

Supplemental Content

Loading ...
Support Center